A durable MOF-nanofiber composite overcomes the fragility of reactive materials, enabling real-world systems that capture and break down nerve agents and toxic industrial gases under harsh conditions.
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results